Conte et al. reported that in CD-1 mice administrated with BLEO intratracheally, Ac-SDKP treatment ameliorated lung fibrosis and collagen deposition of lung tissues and this effect was related to lower expression of TGF-β, IL-17, and α-SMA [112]. This evidence concerns the gene TGFB1 and pulmonary fibrosis.